» Articles » PMID: 26251176

Clinical, Biochemical and Metabolic Characterisation of a Mild Form of Human Short-chain Enoyl-CoA Hydratase Deficiency: Significance of Increased N-acetyl-S-(2-carboxypropyl)cysteine Excretion

Overview
Journal J Med Genet
Specialty Genetics
Date 2015 Aug 8
PMID 26251176
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Short-chain enoyl-CoA hydratase-ECHS1-catalyses many metabolic pathways, including mitochondrial short-chain fatty acid β-oxidation and branched-chain amino acid catabolic pathways; however, the metabolic products essential for the diagnosis of ECHS1 deficiency have not yet been determined. The objective of this report is to characterise ECHS1 and a mild form of its deficiency biochemically, and to determine the candidate metabolic product that can be efficiently used for neonatal diagnosis.

Methods: We conducted a detailed clinical, molecular genetics, biochemical and metabolic analysis of sibling patients with ECHS1 deficiency. Moreover, we purified human ECHS1, and determined the substrate specificity of ECHS1 for five substrates via different metabolic pathways.

Results: Human ECHS1 catalyses the hydration of five substrates via different metabolic pathways, with the highest specificity for crotonyl-CoA and the lowest specificity for tiglyl-CoA. The patients had relatively high (∼7%) residual ECHS1 enzyme activity for crotonyl-CoA and methacrylyl-CoA caused by the compound heterozygous mutations (c.176A>G, (p.N59S) and c.413C>T, (p.A138V)) with normal mitochondrial complex I-IV activities. Affected patients excrete large amounts of N-acetyl-S-(2-carboxypropyl)cysteine, a metabolite of methacrylyl-CoA.

Conclusions: Laboratory data and clinical features demonstrated that the patients have a mild form of ECHS1 deficiency harbouring defective valine catabolic and β-oxidation pathways. N-Acetyl-S-(2-carboxypropyl) cysteine level was markedly high in the urine of the patients, and therefore, N-acetyl-S-(2-carboxypropyl)cysteine was regarded as a candidate metabolite for the diagnosis of ECHS1 deficiency. This metabolite is not part of current routine metabolic screening protocols, and its inclusion, therefore, holds immense potential in accurate diagnosis.

Citing Articles

Crotonylation modification and its role in diseases.

Guo Y, Li J, Zhang K Front Mol Biosci. 2024; 11:1492212.

PMID: 39606030 PMC: 11599741. DOI: 10.3389/fmolb.2024.1492212.


Metformin alleviates cryoinjuries in porcine oocytes by reducing membrane fluidity through the suppression of mitochondrial activity.

Zhou D, Liu H, Zheng L, Liu A, Zhuan Q, Luo Y Commun Biol. 2024; 7(1):925.

PMID: 39090373 PMC: 11294456. DOI: 10.1038/s42003-024-06631-6.


Germline status and micronutrient availability regulate a somatic mitochondrial quality control pathway via short-chain fatty acid metabolism.

Held J, Dbouk N, Strozak A, Grub L, Ryou H, Schaffner S bioRxiv. 2024; .

PMID: 38826313 PMC: 11142046. DOI: 10.1101/2024.05.20.594820.


Transcriptomic profiling of an evolved Yarrowia lipolytica strain: tackling hexanoic acid fermentation to increase lipid production from short-chain fatty acids.

Morales-Palomo S, Navarrete C, Luis Martinez J, Gonzalez-Fernandez C, Tomas-Pejo E Microb Cell Fact. 2024; 23(1):101.

PMID: 38566056 PMC: 10988856. DOI: 10.1186/s12934-024-02367-4.


Molecular and in silico investigation of a novel ECHS1 gene mutation in a consanguine family with short-chain enoyl-CoA hydratase deficiency and Mt-DNA depletion: effect on trimer assembly and catalytic activity.

Maalej M, Sfaihi L, Fersi O, Khabou B, Ammar M, Felhi R Metab Brain Dis. 2024; 39(4):611-623.

PMID: 38363494 DOI: 10.1007/s11011-024-01343-6.